Orchid Pharma inks tech transfer pact with biotechnology firm for 7ACA project
The Chennai-based pharmaceutical manufacturer did not disclose the name of the biotech firm or further details of the agreement11-07-2023
11-07-2023
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 201511-07-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Disclosure under Regulation 30 of SEBI (LODR) Regulation, 201508-07-2023
Orchid Pharma Ltd - 524372 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Massachusetts Institute of Technology & PACs30-06-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Allotment
Disclosure under Regulation 30 of SEBI LODR - Allotment of Equity Shares27-06-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placement
Outcome of the Board Meeting held on June 27, 202327-06-2023
Orchid Pharma shares hit 52-week high; locked in 5% upper circuit for the second day
The stocks are rallying after Orchid Pharma launched a QIP to raise funds last week26-06-2023
Orchid Pharma shares hit 52-week high, rise 5% on launching QIP to raise funds
Stock market today: Orchid Pharma's share price hits new 52-week high as the drugmaker launches Qualified Institutional Placement issuance to raise capital.23-06-2023
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of The Board Meeting
outcome of the Board Meeting22-06-2023